ANDREW LARSEN: Open Payments
NPI 1669841920 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$613 in 28 payments from 10 companies in 2025. Trend: 2023 $404 · 2024 $1,107 · 2025 $613
Food & beverage: $613
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $129 |
| ABBVIE INC. | 5 | $121 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $89 |
| Novartis Pharmaceuticals Corporation | 3 | $85 |
| GENZYME CORPORATION | 3 | $59 |
| Organon LLC | 3 | $52 |
| Galderma Laboratories, L.P. | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
Products named: TREMFYA, ILUMYA, SKYRIZI, DUPIXENT, COSENTYX, RINVOQ, Rhapsido, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
